Leukemias: Related News

On Our Blog

How Do I Decide Whether I Should Bank Cord Blood from My Newborn?

In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.

July 24, 2013

Meet Leukemia Expert Dan Douer

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

April 10, 2013

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

March 20, 2013

Meet Leukemia Expert Stephen Chung

Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

March 18, 2013

New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

March 13, 2013

Meet Leukemia Expert Martin Tallman

Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.

February 27, 2013

Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

September 21, 2012

Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective

Memorial Sloan-Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.

September 6, 2012

Pictured: Natural Killer Cells & Cancer Cell

Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

September 4, 2012

Memorial Sloan-Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

March 26, 2012

Genetic Profiling Could Help Doctors Make More-Accurate Leukemia Prognoses

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

March 15, 2012

Cell-Based Therapies Show Promise

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

December 28, 2011

Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

December 20, 2011

Researchers Discover Imatinib’s Effect Is Due Partly to Immune System

A surprising discovery has been made about how the cancer drug imatinib (Gleevec ®) works in treating blood cancers and gastrointestinal stromal tumors.

December 9, 2011

Memorial Sloan-Kettering Researchers Discover How Gene Mutation Contributes to Leukemia

A study led by researchers at Memorial Sloan-Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.

October 21, 2011

Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.

December 1, 2008

Related Media Coverage

Gene Mutation Contributes To Leukemia By Enhancing Function Of Blood Stem Cells

Memorial Sloan-Kettering researchers helped to identify a key insight into what first goes wrong in the development of many leukemias.

June 30, 2011

Martin S. Tallman Named Chief of the Leukemia Service in the Department of Medicine

Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan-Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.

May 11, 2010

Novel Mechanism Found That May Boost Impaired Function of Leukemia Protein

A new study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.

February 29, 2008

Protein Regulates Quiescent Blood Stem Cells that Are Linked to Enhanced Recovery from Radiation and Chemotherapy

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.

March 13, 2006